MOESM1 of Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG)

Schernthaner, Guntram; Lehmann, Roger; Prázný, Martin; Czupryniak, Leszek; Ducena, Kristine; Fasching, Peter; Janež, Andrej; Karasik, Avraham; Kempler, Peter; Martinka, Emil; Shestakova, Marina; Duvnjak, Lea; Tankova, Tsvetalina

doi:10.6084/m9.figshare.c.3911593_D1.v1

12933_2017_622_MOESM1_ESM.pdf (215.39 kB)

MOESM1 of Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG)

journal contribution

posted on 2017-10-23, 05:00 authored by Guntram Schernthaner, Roger Lehmann, Martin Prázný, Leszek Czupryniak, Kristine Ducena, Peter Fasching, Andrej Janež, Avraham Karasik, Peter Kempler, Emil Martinka, Marina Shestakova, Lea Duvnjak, Tsvetalina Tankova

Additional file 1. Round 1 questionnaire.

Funding

Boehringer Ingelheim

History

Usage metrics

Keywords

Type 2 diabetes Anti-glycaemic drugs Cardiovascular disease Renal disease

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

MOESM1 of Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG)

Funding

Boehringer Ingelheim

History

Usage metrics

Categories

Keywords

Licence

Exports